Screener
TG Therapeutics TGTX Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $482.58M+274% | $442.21M+235% | $79.15M-56.0% | $74.08M-62.2% | $129.13M+55.7% | ||
| $401.57M+73.5% | $392.05M+106% | $305.63M+137% | $265.38M+129% | $231.52M+177% | ||
| $75.49M-51.4% | $26.35M-83.3% | $15.69M— | $146.95M+73.6% | $155.2M+91.0% | ||
| $1.15B+72.6% | $1.09B+68.7% | $630.76M+11.4% | $599.77M+4.5% | $663.96M+70.6% | ||
| $69.67M-43.2% | $72.22M-49.9% | $62.82M-52.1% | $57.5M-60.4% | $122.74M-8.6% | ||
| $1.64B+133% | $1.53B+133% | $1.06B+84.1% | $1.03B+74.9% | $702.61M+75.1% | ||
| $213.69M+59.4% | $148.85M+11.1% | $107.51M+84.4% | $112.34M+10.8% | $134.02M+43.4% | ||
| $14.53M+771% | $6.86M+4.0% | $8.81M-27.1% | $8.35M-48.4% | $1.67M-55.5% | ||
| $268.49M+56.2% | $187.11M+16.8% | $153.76M+69.6% | $156.81M+25.3% | $171.89M+58.2% | ||
| $745.39M+204% | $745.14M+204% | $245.65M+0.5% | $245.34M+0.5% | $245.04M+139% | ||
| $1.04B+143% | $945.71M+125% | $415.23M+16.9% | $417.81M+6.1% | $426.18M+90.6% | ||
| $160K+0.6% | $160K+0.6% | $159K+1.9% | $159K+1.9% | $159K+2.6% | ||
| -$1.05B+29.5% | -$1.06B+30.3% | -$1.08B+29.2% | -$1.11B+28.8% | -$1.5B+3.9% | ||
| $604.08M+119% | $583.13M+146% | $648.02M+191% | $607.22M+216% | $276.43M+55.7% | ||
| $1.64B+133% | $1.53B+133% | $1.06B+84.1% | $1.03B+74.9% | $702.61M+75.1% |
FAQ
- What are TG Therapeutics's total assets?
- TG Therapeutics (TGTX) holds $1.6B in total assets, up 133.4% year over year.
- How much debt does TG Therapeutics have?
- TG Therapeutics carries $754.4M in total debt against $604.1M of shareholders' equity, a debt-to-equity ratio of 1.25.
- How much cash does TG Therapeutics have?
- TG Therapeutics holds $482.6M in cash and equivalents.
- Can TG Therapeutics cover its short-term obligations?
- Its current ratio is 4.27 — current assets exceed current liabilities.
- Where does TG Therapeutics's balance sheet data come from?
- Every line is extracted from TG Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
